Fetus as a patient in pregnant women with COVID-19
Contenido principal del artículo
Resumen
Fetus and placenta are an immunologically privileged unit, whose physiological changes during pregnancy intervenes in the behavior
against SARS-CoV- 2, describing a theoretical potential teratogenic damage due to receptors ACE-2 expression, necessary for SARS-CoV-2 intracellular transport in the epiblast, vital in organogenesis, as well as the current pharmacological therapy teratogenic effects, abortions, and fetal demise.
against SARS-CoV- 2, describing a theoretical potential teratogenic damage due to receptors ACE-2 expression, necessary for SARS-CoV-2 intracellular transport in the epiblast, vital in organogenesis, as well as the current pharmacological therapy teratogenic effects, abortions, and fetal demise.
Descargas
Los datos de descargas todavía no están disponibles.
Detalles del artículo
Cómo citar
Rivero Fraute, A., Cabrera, C., Faneite, P., Vigil-De Gracia, P., & Cuadra, C. (2021). Fetus as a patient in pregnant women with COVID-19. Gaceta Médica De Caracas, 129(2), 415–420. Recuperado a partir de http://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/22503
Número
Sección
ARTÍCULOS DE REVISIÓN